Patents by Inventor Jayana Pankaj Lineswala

Jayana Pankaj Lineswala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted [1,2,4]triazolo[4,3-a]pyrazines as phosphodiesterase inhibitors
    Patent number: 11453673
    Abstract: The present invention provides a compound of Formula I: wherein R1 is methyl, ethyl or cyclopropyl; R2 is hydrogen, methyl, or ethyl; R3 is methyl or AA; and R4 is C2-C4 alkyl, BB; or a pharmaceutically acceptable salt thereof; for use as a PDE1 inhibitor.
    Type: Grant
    Filed: January 13, 2019
    Date of Patent: September 27, 2022
    Assignee: ELI LILLY AND COMPANY
    Inventors: Nicholas Paul Camp, Chafiq Hamdouchi, Jayana Pankaj Lineswala, John Richard Morphy, Qing Shi
  • [1,2,4]TRIAZOLO[4,3-A]PYRAZIN-8-ONE DERIVATIVES
    Publication number: 20200399277
    Abstract: The present invention provides a compound of Formula I: wherein R1 is methyl, ethyl or cyclopropyl; R2 is hydrogen, methyl, or ethyl; R3 is methyl or AA; and R4 is C2-C4 alkyl, BB; or a pharmaceutically acceptable salt thereof; for use as a PDE1 inhibitor.
    Type: Application
    Filed: January 13, 2019
    Publication date: December 24, 2020
    Inventors: Nicholas Paul CAMP, Chafiq HAMDOUCHI, Jayana Pankaj LINESWALA, John Richard MORPHY, Qing SHI
  • Spiropiperidine compounds
    Patent number: 8822486
    Abstract: A compound of the formula: or a pharmaceutically acceptable salt thereof as well as a pharmaceutical composition, and a method for treating diabetes.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: September 2, 2014
    Assignee: Eli Lilly and Company
    Inventors: Chafiq Hamdouchi, Jayana Pankaj Lineswala, Pranab Maiti
  • Spiropiperidine compounds
    Patent number: 8383642
    Abstract: A compound of the formula: or a pharmaceutically acceptable salt thereof as well as a pharmaceutical composition, and a method for treating diabetes.
    Type: Grant
    Filed: October 11, 2010
    Date of Patent: February 26, 2013
    Assignee: Eli Lilly and Company
    Inventors: Chafiq Hamdouchi, Jayana Pankaj Lineswala, Pranab Maiti
  • NOVEL SPIROPIPERIDINE COMPOUNDS
    Publication number: 20120220616
    Abstract: A compound of the formula: or a pharmaceutically acceptable salt thereof as well as a pharmaceutical composition, and a method for treating diabetes.
    Type: Application
    Filed: November 19, 2010
    Publication date: August 30, 2012
    Applicant: ELI LILLY AND COMPANY
    Inventors: Chafiq Hamdouchi, Jayana Pankaj Lineswala, Pranab Maiti
  • Novel Spiropiperidine Compounds
    Publication number: 20110092531
    Abstract: A compound of the formula: or a pharmaceutically acceptable salt thereof as well as a pharmaceutical composition, and a method for treating diabetes.
    Type: Application
    Filed: October 11, 2010
    Publication date: April 21, 2011
    Applicant: ELI LILLY AND COMPANY
    Inventors: Chafiq Hamdouchi, Jayana Pankaj Lineswala, Pranab Maiti